DekaBank Deutsche Girozentrale’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-30,000
| Closed | -$158K | – | 1278 |
|
|
2023
Q1 | $158K | Sell |
30,000
-10,000
| -25% | -$52.7K | ﹤0.01% | 1213 |
|
|
2022
Q4 | $398K | Hold |
40,000
| – | – | ﹤0.01% | 1088 |
|
|
2022
Q3 | $887K | Buy |
40,000
+11,550
| +41% | +$256K | ﹤0.01% | 898 |
|
|
2022
Q2 | $699K | Hold |
28,450
| – | – | ﹤0.01% | 958 |
|
|
2022
Q1 | $1.13M | Buy |
28,450
+2,600
| +10% | +$104K | ﹤0.01% | 891 |
|
|
2021
Q4 | $1.53M | Buy |
25,850
+700
| +3% | +$41.3K | ﹤0.01% | 838 |
|
|
2021
Q3 | $1.5M | Sell |
25,150
-20,000
| -44% | -$1.19M | ﹤0.01% | 794 |
|
|
2021
Q2 | $3.99M | Buy |
45,150
+15,000
| +50% | +$1.33M | 0.01% | 577 |
|
|
2021
Q1 | $2.25M | Hold |
30,150
| – | – | 0.01% | 669 |
|
|
2020
Q4 | $2.82M | Buy |
30,150
+6,000
| +25% | +$561K | 0.01% | 586 |
|
|
2020
Q3 | $940K | Buy |
+24,150
| New | +$940K | ﹤0.01% | 772 |
|
|
2019
Q4 | – | Sell |
-25,000
| Closed | -$387K | – | 1164 |
|
|
2019
Q3 | $387K | Sell |
25,000
-25,000
| -50% | -$387K | ﹤0.01% | 798 |
|
|
2019
Q2 | $1.02M | Buy |
+50,000
| New | +$1.02M | 0.01% | 782 |
|
|
2019
Q1 | – | Sell |
-25,000
| Closed | -$293K | – | 1223 |
|
|
2018
Q4 | $293K | Buy |
+25,000
| New | +$293K | ﹤0.01% | 914 |
|